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Purpose: To evaluate the upgrade rate of ultrasonography (US)-guided core-needle biopsy 
(CNB) of the breast for a pure mucocele-like lesion (MLL), to evaluate the clinical and radiologic 
features, and to correlate the image-pathologic features further on to guide the management of 
MLL.
Methods: Between January 2003 and February 2013, 14-gauge US-guided CNB was performed 
in 18,111 cases. Thirty-two cases associated with MLL were identified, and five cases of MLLs 
associated with breast carcinoma or with other high-risk breast lesions (i.e., atypical ductal 
hyperplasia [ADH], papillary lesions, lobular carcinoma in situ, and radial scar complex) were 
excluded. Among these 27 pure MLLs, 21 cases with surgical or vacuum-assisted excision (VAE) 
pathology were included in our study. Medical records, mammograms, and ultrasonograms were 
reviewed for the clinical and radiologic features of the cases. 
Results: Among the 21 cases with pure MLLs at CNB, the final pathology showed a 0% 
proportion of cases upgraded to malignancy. All the 21 cases with either surgical or VAE 
pathology were benign MLLs including three cases of focal involvement of ADH (14.3%). The 
common features were mammographic features of microcalcifications that were round in shape 
and had a grouped distribution. The US features included oval shape, circumscribed margin, 
parallel orientation, complex solid and cystic echo pattern, no posterior feature, and complex 
solid and cystic echoic masses. The predominant Breast Imaging Reporting and Data System (BI-
RADS) category was 4A. All the lesions showed image-pathologic concordance. 
Conclusion: For pure MLL on US-guided CNB with image-pathologic concordance, close imaging 
follow-up might be considered instead of surgical excision. 
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Introduction
Mucocele-like lesion (MLL) of the breast was originally described 
as a benign lesion composed of multiple cysts lined by cytologically 
uniform flat or cuboidal to columnar epithelium with extravasated 
mucin [1]. Later reports have shown an association of MLL with 
columnar cell lesions (CCLs), atypical ductal hyperplasia (ADH), 
ductal carcinoma in situ (DCIS), and mucinous carcinoma, and have 
suggested that MLL and mucinous carcinoma may represent the two 
ends of the pathological spectrum of the mucinous lesions of the 
breast [2].
Despite the well-known reliability of core-needle biopsy (CNB) 
as a diagnostic method for breast lesions, there are conflicting 
reports about the sufficiency of CNB to diagnose benign MLLs; 
therefore, due to the limited material available on CNB specimen, 
paucicellular mucinous carcinoma cannot be excluded [3-8]. Owing 
to the risk of associated malignancy, excisional biopsy is suggested 
after the identification of MLL on CNB, particularly when the mass 
is palpable or radiologically evident, or when the sample exhibits 
ADH [6,7]. However, for pure MLL on CNB, that is, MLL without any 
associations with CCL, ADH, DCIS, or invasive cancer, some recent 
reports have suggested that excision is unnecessary [1,9]. Still, there 
are limited studies regarding the clinical and radiologic features that 
can help to predict malignancy or the image-pathologic correlation 
of pure MLLs diagnosed on CNB to determine which lesions truly 
require or do not require excision. The purpose of this study was 
to evaluate the outcome and the clinical and radiologic features of 
pure MLLs diagnosed on CNB, and to further correlate their image-
pathologic features in order to guide their appropriate management. 
Materials and Methods
Patients
This retrospective review of images and medical records was 
approved by the Institutional Review Board of our institution, and 
the requirement for informed patient consent was waived. We 
retrospectively reviewed the pathology results dated from January 
2003 to February 2013 in the CNB database files at our institution. 
Out of 18,111 cases of ultrasonography (US)-guided CNB, 32 cases 
associated with MLLs were identified. All the MLLs associated with 
breast carcinoma (i.e., DCIS and invasive cancer) or with other high-
risk breast lesions (such as ADH, papillary lesions, lobular carcinoma 
in situ, CCL, and radial scar complex) were excluded from this study, 
and 27 cases of pure MLL were identified. Among these 27 cases, 
six cases were also excluded because there was neither surgical nor 
vacuum-assisted excision (VAE) pathology. Among these cases, there 
were 19 cases with surgical pathology and two cases with VAE 
pathology. The collected data of each patient included the patient’s 
medical records of age, symptoms, and family history of breast 
cancer along with radiological and excision histology findings.
Imaging Evaluation and Biopsy
Mammographic images were obtained with dedicated film 
mammographic equipment (DMR, General Electric Medical Systems, 
Milwaukee, WI, USA) until April 2005 and two full-field digital 
mammography systems (Selenia, Lorad/Hologic, Danbury, CT, USA; 
Senogaphe DS, General Electric Medical Systems) after May 2005. 
Routine craniocaudal and mediolateral oblique views were obtained, 
and additional mammographic views were obtained as needed. 
US was performed by one of seven radiologists with 3-16 years 
of experience in breast imaging by using a high-resolution US unit 
with 5- to 10-MHz or - to 12-MHz linear-array transducers (HDI 
5000 or 3000, Philips Advanced Technology Laboratories, Bothell, 
WA, USA; Logic 9, General Electric Medical Systems; or iU22, Philips 
Medical Systems, Bothell, WA, USA). All the breast US examinations 
were performed using handheld real-time US. Bilateral whole-breast 
scanning in every examination was performed for both screening 
and diagnostic purposes.
When microcalcifications were noted on mammography, a 
radiopaque marker was attached on the skin of the US noted lesion, 
the lesion which was to undergo subsequent biopsy. Additional 
routine craniocaudal and mediolateral oblique mammograms were 
conducted, and whether the microcalcifications on mammography 
were correlated with the US lesion or not was evaluated. The biopsy 
procedures were performed by one of seven radiologists with 3-16 
years of experience in breast imaging. Tissue samples were obtained 
using a 14-gauge dual-action semiautomatic core biopsy needle 
(Stericut with coaxial, TSK Laboratory, Tochigi, Japan). 
US-Guided VAE
The VAE procedure was performed using a vacuum-assisted device 
(Mammotome, Ethicon-Endosurgery, Cincinnati, OH, USA) with an 
8- or an 11-gauge probe under the guidance of the high-resolution 
US unit mentioned above, as described by Kim et al. [10]. The VAE 
procedure was performed by one of four radiologists with 4-11 
years of experience in breast imaging and US-guided biopsy.
Surgery and Follow-up
Surgery was performed by one of two breast surgeons with 9 and 
16 years of experience in breast surgery, respectively. In cases of 
nonpalpable lesions, US-guided preoperative needle localization or 
US-guided preoperative skin marking was performed. 
Pure mucocele-like lesion of breast
e-ultrasonography.org Ultrasonography 34(2), April 2015 135
Data Collection and Statistical Analysis
After the review of the VAE and surgical results, the final diagnoses 
were categorized as either upgrade to malignancy (DCIS or invasive 
carcinoma) or benign (including high-risk lesions). An upgrade to 
malignancy of a pure MLL was determined when the finding of pure 
MLL was changed to malignancy at VAE or surgical pathology. The 
lesions that were not removed by VAE or surgery and that were 
stable after a year of follow-up after the biopsy were considered 
benign.
Images were reviewed in consensus by two radiologists with 
3 and 16 years of experience in breast imaging. Mammographic 
features including mammographic breast density, mammographic 
findings, the presence of microcalcifications, and the morphology 
and distribution of microcalcifications on mammography were 
assessed. US features and the final assessment category according 
to the American College of Radiology’s Breast Imaging Reporting 
and Data System (BI-RADS) were assessed. The following US 
features were determined according to the terminology of the fifth 
American College of Radiology BI-RADS [11]: size, shape, margin, 
orientation, echo pattern, and posterior features. Regarding the echo 
pattern, a complex cystic and solid echoic mass was additionally 
classified as a complicated cyst, cyst with thin septations, cystic mass 
with thick wall and/or thick septations, intracystic mass (mixed cystic 
and solid appearance), and solid mass with eccentric cystic foci [12]. 
Complicated cysts could also have fluid-fluid or fluid-debris levels 
that might shift with changes as a result of patient position [11]. 
After reviewing both the mammographic and US features, the final 
assessment categorization was done on the basis of the combination 
of the two imaging studies. Category 4 was subclassified into 4A (low 
suspicion), 4B (moderate suspicion), and 4C (high suspicion). 
Results
Among the 21 pure MLLs at CNB, the final pathology showed no 
upgrade to malignancy. All the 21 cases with pathology obtained 
by either VAE or surgery were benign MLLs including three cases 
of focal involvement of ADH (14.3%). The age range of the 21 
patients with pure MLL at CNB was 27-76 years (mean, 45±11 
years). There was no patient with a family history of breast cancer. 
Seventeen patients (81.0%) had no symptoms, and the lesions were 
detected on a screening examination; four patients (19.0%) were 
symptomatic. The symptoms were palpability (n=2), nipple discharge 
(n=1), and pain (n=1).
Mammography was available in 19 cases, and the findings 
Table 1. Mammographic features of pure mucocele-like lesions 
that underwent ultrasonography-guided 14-gauge core-needle 
biopsy
Variable No. (%) (n=19)
Size, mean±SD (mm) 10.8±3.7
Mammographic density
   Scattered fibroglandular tissue 2 (10.5)
   Heterogeneously dense 17 (89.5)
Mammographic finding
   Negative 5 (31.3)
   Asymmetry or mass without microcalcifications 4 (21.1)
   Microcalcifications only 10 (47.6)
   Morphology of microcalcifications
Round 5 (50.0)
Punctate 1 (10.0)
Amorphous 1 (10.0)
Coarse heterogeneous 1 (10.0)
   Fine pleomorphic 2 (20.0)
                    Distribution of microcalcifications
   Diffuse 3 (30.0)
   Grouped 7 (70.0)
Table 2. Ultrasonographic features for pure mucocele-like 
lesions that underwent ultrasonography-guided 14-gauge core-
needle biopsy
Ultrasonographic finding No. (%) (n=21)
Size, mean±SD (mm) 9.2±1.9
Shape
   Oval 20 (95.2)
   Irregular 1 (4.8)
Margin
   Circumscribed 16 (76.2)
   Microlobulated 5 (23.8)
Orientation
   Parallel 19 (90.5)
   Not parallel 2 (9.5)
Echo pattern
   Anechoic 1 (4.8)
   Complex cystic and solid 20 (95.2)
Posterior features
   None 16 (76.2)
   Enhancement 5 (23.8)
BI-RADS category
   3 7 (33.3)
   4A 9 (42.8)
   4B 5 (23.8)
BI-RADS, Breast Imaging Reporting and Data System.
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in 10 cases (47.6%). In all cases, microcalcifications were located 
in the mass. The classification of complex solid and cystic echoic 
masses is presented in Table 3. Nine lesions (45.0%) showed 
intracystic mass (mixed cystic and solid appearance) (Fig. 1), and five 
lesions (25.0%) showed cystic mass with thick walls and/or thick 
septations. All the lesions showed image-pathologic concordance. 
Discussion
Few publications have addressed pure MLL with in situ or invasive 
carcinoma as an upgrade to malignancy [1,9]. Our study defined 
and included MLLs that were upgraded into in situ or invasive 
carcinoma, since a diagnosis of ADH is not treated as MLL with 
in situ or invasive carcinoma. Further, including MLL with ADH as 
an upgrade could overestimate the risk associated with pure MLL 
diagnosed using US-guided 14-gauge CNB. The previous two studies 
on only pure MLL that was upgraded to DCIS show 0% and 4% 
upgrade rates, which is similar to our study [1,9].
Whether the microcalcifications can be a predictive factor to 
distinguish benign MLLs from malignant MLLs is controversial. 
Some suggest that the number, shape, and distribution of 
microcalcifications are not generally helpful in differentiating benign 
from malignant MLLs [2,13]. However, a 2005 study by Kim et al. [14] 
suggested that the microcalcifications of malignant MLLs extended 
over a wider area than those of benign MLLs. Our result correlated 
with that of Kim et al. [14]: a majority of microcalcifications of all 
are summarized in Table 1. The lesion size in the four cases with 
asymmetry or mass without microcalcifications on mammography, 
was 10-16 mm (mean, 12 mm), that in three cases with a diffuse 
distribution of microcalcifications was larger than 10 mm, and 
that in seven cases with grouped microcalcifications was 5-18 
mm (mean, 9.2 mm). Microcalcifications were the most common 
mammographic feature (47.6%), and most of them were round 
in shape (50.0%) and had a grouped distribution (70.0%) (Fig. 
1). The US features are presented in Table 2. The mean size of the 
lesions was 9.2±1.9 mm. The representative US features were oval 
shape (95.2%), circumscribed margin (76.2%), parallel orientation 
(90.5%), complex solid and cystic echo pattern (95.2%), and no 
posterior feature (76.2%). The most predominant BI-RADS category 
was category 4A (42.8%). Microcalcifications were shown on US 
Table 3. Classification of complex solid and cystic echoic masses 
for pure mucocele-like lesions that underwent ultrasonography-
guided 14-gauge core-needle biopsy
Classification of the complex solid and cystic 
echoic masses 
No. (%) 
(n=20)
Complicated cyst 0 (0)
Cyst with thin septations 5 (25.0)
Clustered microcysts 1 (5.0)
Cystic mass with thick wall and/or thick septations 5 (25.0)
Intracystic mass (mixed cystic and solid appearance) 9 (45.0)
Solid mass with eccentric cystic foci 0 (0)
Fig. 1. A 36-year-old woman with pure mucocele-like lesion (MLL). 
A. A magnification mammography mediolateral view shows grouped coarse heterogeneous microlcalcifications in the right upper breast. B. 
A transverse sonogram shows a 7-mm oval-shaped circumscribed marginated complex cystic and solid echoic lesion showing an intracystic 
mass (mixed cystic and solid appearance) with microcalcifications. The lesion was categorized as Breast Imaging Reporting and Data System 
(BI-RADS) category 4A. The pathologic result of core biopsy was pure MLL with microcalcifications, and it was considered concordant with 
the imaging findings. The mass was surgically excised and was proven to be benign MLL on surgical pathology.
A B
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the benign lesions in our study were clustered in the distribution 
(70.0%).
In terms of US features, it has been reported that US features 
do not help to differentiate between benign and malignant MLLs 
[15]. However, certain findings were predominant in the benign 
lesions considered in our study. The US feature of oval shape was 
the common finding in all the benign lesions in our study, and we 
think that this could be a distinguishing feature of benign and 
malignant MLLs (95.2%). This is supported by two previous studies 
suggesting the final pathology of mucinous carcinoma presenting 
as a well-defined or irregular-shaped solid mass on US and MLLs 
associated with DCIS presenting as irregular-shaped masses [2,7]. 
The circumscribed margin on US was the most common feature 
of the lesions considered in our study (76.2%). To the best of our 
knowledge, only one study, that by Carkaci et al. [2], has addressed 
the mass margin as the differential feature of benign and malignant 
MLLs. The study is in agreement with our study that the masses 
representing MLL with or without ADH had margins that were 
mostly circumscribed.
Although ultrasound elastography has not been performed in our 
study, it has been reported to be useful in differentiating benign and 
malignant breast masses, and this is supported by the fifth edition of 
the BI-RADS [11,16-18]. To the best of our knowledge, the efficacy 
of ultrasound elastography as a tool for distinguishing benign from 
malignant complex cystic and solid echoic masses has been reported 
by only one study, and a future study regarding its efficacy as a 
diagnostic tool is recommended [19].
As for the management of pure MLLs on US-guided CNB, 
controversy remains on whether CNB of an MLL is sufficient to 
diagnose benign pathology and thus, to avoid surgical excision [2]. 
The studies that pertain to surgical excision for the management of 
pure MLLs at CNB suggest a high upgrade rate of up to 43% [20-
22]. Such a high upgrade rate can be explained by the inclusion of 
lesions with ADH as an upgrade [4,5]. However, our study and the 
two previous studies that include only MLLs with in situ and invasive 
carcinoma as an upgrade, showed low upgrade rates of 0%-4.3%, 
indicating that surgical excision in all the cases of pure MLL at CNB 
is not desirable [1,9].
Previous studies have suggested that if vacuum-assisted biopsies 
have removed the entire radiological abnormality, in the setting of 
image-pathologic concordance, it may be possible to avoid surgical 
excision. Given the low upgrade rate and the fact that all the benign 
lesions in our study showed image-pathologic concordance, for 
lesions with image-pathologic concordance and the representative 
clinical and imaging features of benign MLLs, we agree with the 
suggestion of other authors that VAE should be conducted for 
complete removal of the radiologic abnormality and no further 
surgical excision should be carried out [3,5,6]. For only the lesions 
with image-pathologic discordance, we recommend surgical 
excision.
Our study had several l imitations. First, the study was 
retrospective, and real-time US features were not available at the 
time of review; further, sonographic features were interpreted with 
static images. Although an expert in breast US performed all breast 
US, there might have been interobserver variability. To overcome 
this interobserver variability, two radiologists reviewed all of the 
static images retrospectively; however, some effect of the operator 
dependency of breast US could have remained. A prospective study 
is needed to overcome this limitation. Second, there was no case of 
upgrade to malignancy, and therefore, the findings of our study were 
not statistically supported. A further study with a larger population 
and a prospective design is needed.
In conclusion, depending on the features of a 0% upgrade rate to 
malignancy for all the 21 pathologically proven lesions in this study, 
a close imaging follow-up might be considered instead of surgical 
excision for pure MLL on US-guided CNB with image-pathologic 
concordance.
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